139 related articles for article (PubMed ID: 32162890)
21. Small RNA sequencing profiles of mir-181 and mir-221, the most relevant microRNAs in acute myeloid leukemia.
Lee YG; Kim I; Oh S; Shin DY; Koh Y; Lee KW
Korean J Intern Med; 2019 Jan; 34(1):178-183. PubMed ID: 29172404
[TBL] [Abstract][Full Text] [Related]
22. Downregulated miR-217 expression predicts a poor outcome in acute myeloid leukemia.
Yan J; Wu G; Chen J; Xiong L; Chen G; Li P
Cancer Biomark; 2018; 22(1):73-78. PubMed ID: 29439315
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
24. TUG1 confers Adriamycin resistance in acute myeloid leukemia by epigenetically suppressing miR-34a expression via EZH2.
Li Q; Song W; Wang J
Biomed Pharmacother; 2019 Jan; 109():1793-1801. PubMed ID: 30551433
[TBL] [Abstract][Full Text] [Related]
25. CircRNA circ_POLA2 is Upregulated in Acute Myeloid Leukemia (AML) and Promotes Cell Proliferation by Suppressing the Production of Mature miR-34a.
Li H; Bi K; Feng S; Wang Y; Zhu C
Cancer Manag Res; 2021; 13():3629-3637. PubMed ID: 33981162
[TBL] [Abstract][Full Text] [Related]
26. High serum microRNA-335 level predicts aggressive tumor progression and unfavorable prognosis in pediatric acute myeloid leukemia.
Lin X; Wang Z; Zhang R; Feng W
Clin Transl Oncol; 2015 May; 17(5):358-64. PubMed ID: 25301405
[TBL] [Abstract][Full Text] [Related]
27. Assessment of the Diagnostic Potential of miR-29a-3p and miR-92a-3p as Circulatory Biomarkers in Acute Myeloid Leukemia.
Gado MM; Mousa NO; Badawy MA; El Taweel MA; Osman A
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3625-3633. PubMed ID: 31870103
[TBL] [Abstract][Full Text] [Related]
28. Down-Regulation of miR-186 Correlates with Poor Survival in de novo Acute Myeloid Leukemia.
Zhang TJ; Wang YX; Yang DQ; Yao DM; Yang L; Zhou JD; Deng ZQ; Wen XM; Guo H; Ma JC; Lin J; Qian J
Clin Lab; 2016; 62(1-2):113-20. PubMed ID: 27012040
[TBL] [Abstract][Full Text] [Related]
29. The clinical characteristics and prognostic significance of MN1 gene and MN1-associated microRNA expression in adult patients with de novo acute myeloid leukemia.
Xiang L; Li M; Liu Y; Cen J; Chen Z; Zhen X; Xie X; Cao X; Gu W
Ann Hematol; 2013 Aug; 92(8):1063-9. PubMed ID: 23515710
[TBL] [Abstract][Full Text] [Related]
30. Correlation of miR-181a and three HOXA genes as useful biomarkers in acute myeloid leukemia.
Xu P; Zhou D; Yan G; Ouyang J; Chen B
Int J Lab Hematol; 2020 Feb; 42(1):16-22. PubMed ID: 31670914
[TBL] [Abstract][Full Text] [Related]
31. Decreased miR-144 expression as a non-invasive biomarker for acute myeloid leukemia patients.
Zhao Q; Li J; Chen S; Shen K; Ai G; Dai X; Xie B; Shi Y; Jiang S; Feng J; Li W
Pharmazie; 2017 Apr; 72(4):232-235. PubMed ID: 29441994
[TBL] [Abstract][Full Text] [Related]
32. [Expression and Clinical Significance of PD-L1 and MicroRNA-138-5p in Patients with Acute Myeloid Leukemia].
Huang CY; Zha XF; Wen WR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):373-378. PubMed ID: 30998140
[TBL] [Abstract][Full Text] [Related]
33. Distinct power of bone marrow microRNA signatures and tumor suppressor genes for early detection of acute leukemia.
Memari F; Tavakolpour V; Mohajeri N; Poopak B; Fallah P; Alizadeh E; Kouhkan F; Zarghami N
Clin Transl Oncol; 2022 Jul; 24(7):1372-1380. PubMed ID: 35247197
[TBL] [Abstract][Full Text] [Related]
34. Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients.
Butrym A; Rybka J; Baczyńska D; Tukiendorf A; Kuliczkowski K; Mazur G
J Exp Clin Cancer Res; 2015 Jul; 34(1):68. PubMed ID: 26126974
[TBL] [Abstract][Full Text] [Related]
35. Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia.
Tian C; Zhang L; Li X; Zhang Y; Li J; Chen L
Cancer Biomark; 2018; 22(2):209-215. PubMed ID: 29689705
[TBL] [Abstract][Full Text] [Related]
36. miR-29a and miR-142-3p downregulation and diagnostic implication in human acute myeloid leukemia.
Wang F; Wang XS; Yang GH; Zhai PF; Xiao Z; Xia LY; Chen LR; Wang Y; Wang XZ; Bi LX; Liu N; Yu Y; Gao D; Huang BT; Wang J; Zhou DB; Gong JN; Zhao HL; Bi XH; Yu J; Zhang JW
Mol Biol Rep; 2012 Mar; 39(3):2713-22. PubMed ID: 21678057
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of miR-29a expression in pediatric acute myeloid leukemia.
Zhu C; Wang Y; Kuai W; Sun X; Chen H; Hong Z
Clin Biochem; 2013 Jan; 46(1-2):49-53. PubMed ID: 22981932
[TBL] [Abstract][Full Text] [Related]
38. Interaction between 12p chromosomal abnormalities and Lnc-HOTAIR mediated pathway in acute myeloid leukemia.
El-Khazragy N; Ghozy S; Matbouly S; Zaki W; Safwat G; Hussien G; Khalifa O
J Cell Biochem; 2019 Sep; 120(9):15288-15296. PubMed ID: 31038787
[TBL] [Abstract][Full Text] [Related]
39. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O
Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598
[TBL] [Abstract][Full Text] [Related]
40. Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia.
Zhou JD; Zhang LC; Zhang TJ; Gu Y; Wu DH; Zhang W; Ma JC; Wen XM; Guo H; Lin J; Qian J
J Transl Med; 2018 May; 16(1):135. PubMed ID: 29784043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
